Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi
- 31 July 2012
- journal article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 40 (1), 61-71
- https://doi.org/10.1016/j.ijantimicag.2012.03.009
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Financiadora de Estudos e Projetos (FINEP)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
This publication has 28 references indexed in Scilit:
- Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensisMolecular Biology International, 2011
- Amiodarone Inhibits Trypanosoma cruzi Infection and Promotes Cardiac Cell Recovery with Gap Junction and Cytoskeleton Reassembly In VitroAntimicrobial Agents and Chemotherapy, 2011
- Advances in Chagas disease drug development: 2009–2010Current Opinion in Infectious Diseases, 2010
- In Vitro and In Vivo Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' DiseaseAntimicrobial Agents and Chemotherapy, 2010
- A Nonazole CYP51 Inhibitor Cures Chagas’ Disease in a Mouse Model of Acute InfectionAntimicrobial Agents and Chemotherapy, 2010
- Chagas diseaseThe Lancet, 2010
- Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus ErythematosusThe American Journal of Tropical Medicine and Hygiene, 2010
- A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVIMemórias do Instituto Oswaldo Cruz, 2009
- Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteersJournal of Clinical Pharmacy & Therapeutics, 2009
- Different cell death pathways induced by drugs in Trypanosoma cruzi: An ultrastructural studyMicron, 2009